녹아웃(KO) 마우스 | Cyagen Korea

Citations

What Our Customers Say

“Among several commercial services who have claimed to be specialized to generate mouse models with genetic modifications, I recognize that Cyagen is one of the best. We are looking forward to having more cooperation with them.”

Korea Brain Research Institute (KBRI)

more ›

Contact Us

영업일 기준 1-2일 내에 답변해 드리겠습니다.

*

The username is required

*

The user's email is required

Please enter a valid email address.

*

The user's phone is required

Please enter a valid phone address.

*

The content is required

*

 

 

Strain Background: C57BL/6N

 

Construction Strategy:

The double-humanized PD-1 and VISTA mouse model (hPD-1/hVISTA) was generated by intercrossing hPD-1 and hVISTA mice. Both hPD-1 and hVISTA expressions are regulated by endogenous mouse promoters.

 

PD-1/VISTA Features:

  •   The PD-1 and VISTA extracellular domains are entirely humanized
  •   Physiological regulation and expression pattern of the human PD-1 and VISTA
  •   Preservation of the target-ligand interaction
  •   Fully functional mouse immune system
  •   Lack of expression of the murine target gene, thus avoiding cross-reactivity

 

Research and Application:

The hPD-1/hVISTA mouse enables the in vivo efficacy and safety assessment of compounds targeting the human immune checkpoint PD-1 and/or VISTA in fully immunocompetent mice.

Use our hPD-1/hVISTA mouse model together with cell line MC38-hPD-L1 as a syngeneic tumor model for testing the efficacy of combination therapies targeting human PD-1 and human PD-L1.

 

Validation Data:

Figure 1. hPD-1 expression pattern in hPD-1/hVISTA mice recapitulates mPD-1 in wild-type mice. hPD-1 and mPD-1 expression on αCD3/αCD28-activated splenocytes for (A) Tregs and (B) conventional CD4+, alongside both (C) hPD-1 expression and mPD-1 expression in CD8+ T cells across hPD-1/hVISTA mice and wild-type mice at the indicated timepoints.    

Figure 2. hVISTA expression pattern in hPD-1/hVISTA mice recapitulates mVISTA in wild-type mice. hVISTA and mVISTA expression on freshly isolated splenocytes on Tregs, conventional CD4+, and CD8+ T cells.

Figure 3. Anti-tumor effects in response to anti-human VISTA + anti-mouse PD-1 treatment. Mice of indicated genotype were inoculated with MC38 tumor cells s.c. and treated αKLH (control), αmPD-1, αhVISTA or αmPD-1 + αhVISTA (combination). In wild-type mice, mPD-1 antibody can inhibit tumor proliferation, while hVISTA antibody can inhibit tumor proliferation in hVISTA mice. The combined antibody therapy of hVISTA and mPD-1 can inhibit tumor growth in hVISTA mice more effectively than either therapy used alone.

Figure 4. In vivo anti-tumor activity in response to pembrolizumab treatment in hPD-1 mice. Implanting GL261 murine glioma cells into wildtype and hPD-1 mice intracranially to detect the effects of different treatments on the survival of mice. In wild-type mice, hPD-1 and mPD-1 antibodies have no significant effect on the survival of mice, while in hPD-1 mice, the treatment of hPD-1 monoclonal antibody pembrolizumab can inhibit tumor growth and prolong the life of mice.

위에 제품이나 서비스에 관심이 있으시면 저희한테 연락 부탁드립니다.

Your First Name can not be empty

Your Last Name can not be empty

Institution/Affiliation can not be empty

Please enter a valid email address.

Your Email can not be empty

The content can not be empty

The option can not be empty